Daniel L. Barber, PhD
@danbarberphd.bsky.social
📤 2326
📥 274
📝 14
Immunologist. Major focus is on T cell responses to Mycobacterium tuberculosis infection.
What we’ve got here is failure to communicate - some macrophages you just can’t reach! Multiple features of granulomas limit effective T cell:MΦ interactions, posing a major barrier for vaccine-mediated protection. Check out our new review!
onlinelibrary.wiley.com/doi/10.1111/...
loading . . .
<em>Journal of Internal Medicine</em> | Wiley Online Library
Tuberculosis (TB) remains a leading infectious cause of morbidity and mortality, and the development of a new, highly effective vaccine would have a tremendous beneficial impact on global health. Alt....
https://onlinelibrary.wiley.com/doi/10.1111/joim.70028
about 1 month ago
2
8
4
Check out our new paper with
@nelson-lab.bsky.social
. We used scRNAseq to profile the function of Mtb peptide-specific T cells from NHP and human lung granulomas. Beyond IFNγ, Mtb-specific T cells make a bunch of unexpected stuff, and human and NHP cell are really similar.
about 1 month ago
2
11
4
We are looking to hire post-docs to work on T cell responses to M. tuberculosis infection using murine and NHP models. If you know T cells and wanna work on the top global infectious killer check us out. BSL3 experience not required. The NIH intramural program in Bethesda MD is an amazing place!
4 months ago
0
19
17
We are looking for post-docs interested in studying T cell responses to M. tuberculosis infection…especially basic T cell immunologists who are interested in learning to work with BSL3 pathogens. The NIH intramural program is an amazing place to train!
7 months ago
0
16
19
reposted by
Daniel L. Barber, PhD
Olivier Neyrolles
10 months ago
Excited to share our last study. Huge congrats to Sarah Monard, Arnaud Métais,
@gclugo.bsky.social
,
@chrisverollet.bsky.social
and all colleagues! We have found a mysterious cell type inside TB lung lesions that seems neuron-like but isn't quite a nerve cell. Let's dive in👇
shorturl.at/x4Sb5
5
69
41
What an incredible analysis!!!
add a skeleton here at some point
11 months ago
0
5
0
reposted by
Daniel L. Barber, PhD
Michael Fischbach
about 1 year ago
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream.
@djenetbousbaine.bsky.social
led the charge...
@natureportfolio.bsky.social
1/55
24
693
359
reposted by
Daniel L. Barber, PhD
Paul Baker
about 1 year ago
Thanks to all of our amazing coauthors including
@kerryhilligan.bsky.social
,
@danbarberphd.bsky.social
for spending many, many hours tolerating me in the BSL3 lab, helping with experiments and data analysis, and providing valuable advice and moral support!
1
5
2
reposted by
Daniel L. Barber, PhD
Paul Baker
about 1 year ago
More details in this 🧵 from my powerhouse PI
@mayerbarber.bsky.social
whose foresight and guidance got us to this fantastic manuscript!
add a skeleton here at some point
2
5
3
reposted by
Daniel L. Barber, PhD
Paul Baker
about 1 year ago
Excited to share this paper from my post-doc at
@niaidnews.bsky.social
out now in Science Immunology! We show that recent or ongoing 🫁 infections or other pulmonary environmental exposures at the time of infection with SARSCoV2 can vastly influence early replication of the virus in mice.
loading . . .
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Recent or ongoing respiratory inflammation in the lung regulates antiviral immune responses to SARS-CoV-2.
https://www.science.org/doi/10.1126/sciimmunol.adp7951
2
37
9
reposted by
Daniel L. Barber, PhD
Kat Mayer-Barber,PhD
about 1 year ago
Best
#Nikolaus
🎅! Our paper on how the 🫁 microenvironment can shape
#innate
immunity against
#viruses
is out
@sciimmunology.bsky.social
This was a herculean effort brilliantly led by
@pauljbaker.bsky.social
who singlehandedly established the model in the lab during the pandemic. 🧪
#Immunosky
1/9
28
295
93
reposted by
Daniel L. Barber, PhD
Kat Mayer-Barber,PhD
about 1 year ago
🙏 to
@niaidnews.bsky.social
, first author
@pauljbaker.bsky.social
and my amazing lab team, our collaborators
@kerryhilligan.bsky.social
@danbarberphd.bsky.social
🙏to editor extraordinaire
@hannah-isles.bsky.social
and the reviewers who guided us along the way 9/9
www.science.org/doi/10.1126/...
loading . . .
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Recent or ongoing respiratory inflammation in the lung regulates antiviral immune responses to SARS-CoV-2.
https://www.science.org/doi/10.1126/sciimmunol.adp7951
3
37
11
reposted by
Daniel L. Barber, PhD
Marc Swidergall
about 1 year ago
Candida auris Infectious by Lionakis & Chowdhary in NEJM
www.nejm.org/doi/full/10....
loading . . .
Candida auris Infections | NEJM
C. auris, a serious public health threat that may have emerged because of climate change, persists on human skin and inanimate objects, frequently causing difficult-to-control outbreaks in health c...
https://www.nejm.org/doi/full/10.1056/NEJMra2402635
0
4
6
reposted by
Daniel L. Barber, PhD
Gabriele Pollara
about 1 year ago
As community here grows, need for starter packs will rapidly be replaced by need to curate timelines. Enter Bluesky's custom feeds! I have made one for tuberculosis / TB posts, though it may lack specificity. Feel free to pin & use it. Feedback welcome
#IDSky
#MedSky
Link👉
bsky.app/profile/did:...
add a skeleton here at some point
4
26
7
reposted by
Daniel L. Barber, PhD
Kat Mayer-Barber,PhD
almost 2 years ago
Excited for my first post here to be our new
#preprint
. 👇🏻check it out below … the recent pulmonary exposure history matters for limiting SARS-CoV-2 viral titers in the 🫁”tweetorial” to follow later
add a skeleton here at some point
0
4
1
you reached the end!!
feeds!
log in